Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production.
about
Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatmentCombination of flucloxacillin and gentamicin inhibits toxic shock syndrome toxin 1 production by Staphylococcus aureus in both logarithmic and stationary phases of growthFar East Scarlet-Like Fever: A Review of the Epidemiology, Symptomatology, and Role of Superantigenic Toxin: Yersinia pseudotuberculosis-Derived Mitogen AStaphylococcal enterotoxin A induces small clusters of HLA-DR1 on B cellsPathogenesis of group A streptococcal infectionsStaphylococcal enterotoxin type A internal deletion mutants: serological activity and induction of T-cell proliferation.Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxinsAggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditisEnhancement of lipopolysaccharide-induced neutrophil oxygen radical production by tumor necrosis factor alphaKetamine inhibits tumor necrosis factor secretion by RAW264.7 murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant Staphylococcus aureusBiochemical and biological properties of Staphylococcal enterotoxin K.Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways.Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1.Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin BStaphylococcal and streptococcal superantigen exotoxinsRole of antigen-presenting cells in activation of human T cells by the streptococcal M protein superantigen: requirement for secreted and membrane-associated costimulatory factorsSimilar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B.Binding and activation of major histocompatibility complex class II-deficient macrophages by staphylococcal exotoxins.Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D.Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8.Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide.Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).Two novel superantigens found in both group A and group C Streptococcus.Do cardiomyocytes mount an immune response to Group A Streptococcus?Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness.Production of tumor necrosis factors alpha and beta by human mononuclear leukocytes stimulated with mitogens, bacteria, and malarial parasitesBacterial superantigens.Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock modelStreptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes.Streptococcus associated toxic shock.Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V beta 5-bearing CD8+ lymphocytesBacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production.Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes.Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein.The carboxyl-terminal region of staphylococcal enterotoxin type A is required for a fully active moleculeFluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxinsCell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity.Identification of a bacteriophage containing a silent staphylococcal variant enterotoxin gene (sezA+).Murine macrophage activation by staphylococcal exotoxinsImproved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1
P2860
Q24648318-F59DC415-C7C4-407B-8CE4-917ACB53BB16Q24670283-6ED7E509-3490-4B62-AEF5-A571A54549C4Q26773071-03AF1276-2A51-4B0A-9BAA-DBC08121DCF4Q27346703-BD98CA64-7AE3-4B0A-9F2E-F24CBF2E845CQ29615547-CD8E2BF8-843F-457A-AF17-BF98F5CC3E7EQ33596933-DBA4C6B7-9C82-44AB-B782-E8D54FEAB73CQ33604268-1F5C5930-FF1F-40BA-905D-078E77FC27B0Q33748332-3188B0AD-E560-46CC-AA8D-C941E9B92B12Q33752705-C9537B97-0D11-4E18-AE10-E91F5E876EE2Q33803430-7FF85A77-FD32-4B3E-855E-D98042BC6BDAQ34005641-0682DC70-92F0-46D6-8E9B-A0225DFF0AA5Q34006182-CE4C045E-E3F5-4EC1-B68A-986F46CEC4B8Q34007530-DBE226E7-8BE6-45CC-9FD6-F8D239F55447Q34123201-2F76E10E-36E5-4AF5-A076-666DC7C510FCQ34355243-DF98890E-D70F-44BB-B9DB-E6DC2E3C4547Q34525449-6434BE7A-F06A-425E-B2CD-FB73901AB4E9Q34536384-CBC484E2-5538-48EA-83F0-804874E7627DQ34537412-2DC57022-BF08-42E9-9DFC-1640B79973C2Q34542346-FC9F354A-C23E-4672-A2F9-1A2A0C28D9BAQ34543940-BA1DA015-9547-4509-8E2B-30834FA7B3B6Q34544467-24AE27C1-B57B-4D35-ABB4-27FD53A62303Q34546630-94DD466C-1F37-47AE-9333-174ABB90F855Q34713856-3B8A8EAE-4697-41DE-A56A-BB1D70FC185AQ34916463-8BB0828B-D7A9-407D-9279-E4A39CEBD45DQ35106948-CFD772F7-4548-4925-B64F-F78F35D513D1Q35109154-507C6534-F771-4F38-B043-3E81D3D1EBCCQ35203877-7DD26AE6-3B86-4BD8-8234-96106413D579Q35471377-5CC2F148-5223-46C9-B1D3-2F37812E51E7Q35555447-A85AF21A-21E8-4BEB-844F-2016FEB3319AQ35627675-7E42B276-F096-4B2B-94F9-58A8EEA86723Q36363672-967A5F5E-E0A0-474B-9506-A7AFA312D13CQ36364381-7751BCA2-639F-4A81-9ABE-5592CC44D8ADQ36949104-50C0AA1D-95C2-4574-9D83-D7EA5D3BC5C1Q36958443-75AB45E4-10BD-4B22-90D2-65F160522317Q36965301-66B61B32-73DE-4A95-8B48-D149CD64D9C0Q36974024-264B47A6-C2F9-477C-9B84-BBF9418BB7ABQ36974989-FC667967-1546-4BB4-B8A8-980A59784FD8Q36982470-7D7EDB51-E7EE-4404-8084-8F6EAF027BB3Q36989002-29731E54-D089-42BF-95BE-5079069B0D71Q37137814-2112D35B-2A0C-44C0-807C-B4C757597D87
P2860
Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Toxic shock syndrome-associate ...... or necrosis factor production.
@ast
Toxic shock syndrome-associate ...... or necrosis factor production.
@en
type
label
Toxic shock syndrome-associate ...... or necrosis factor production.
@ast
Toxic shock syndrome-associate ...... or necrosis factor production.
@en
prefLabel
Toxic shock syndrome-associate ...... or necrosis factor production.
@ast
Toxic shock syndrome-associate ...... or necrosis factor production.
@en
P2093
P2860
P1476
Toxic shock syndrome-associate ...... mor necrosis factor production
@en
P2093
P M Schlievert
R D Nelson
P2860
P304
P407
P577
1989-01-01T00:00:00Z